ADMD, with its new alliance, will have exclusive sales and distribution rights of GSG's Mo-99 and related Tc-99 generators and kits in both North and South America and China. ADMD will also have the ability to obtain additional rights in other territories. This alliance could become quite lucrative for ADMD as the demand for radiotherapy products in Asia and emerging markets have heated up. And companies that manufacture radiotherapy equipment are now focusing on these markets, which means there will be a greater need for medical isotopes and kits. With mature markets, such as the U.S., dominating the space, and Europe with radioisotope sales estimated to be $1.1 billion in 2012 it is expected to see Mo-99/Tc-99 usage grow from 2010 to 2020 at an annual rate of 1.8%.